自闭症谱系障碍的神经反馈。

Neurofeedback in autism spectrum disorders.

机构信息

LWL-University Hospital for Child and Adolescent Psychiatry, Psychotherapy and Psychosomatics of the Ruhr University Bochum, Hamm, Germany.

出版信息

Dev Med Child Neurol. 2011 Nov;53(11):986-93. doi: 10.1111/j.1469-8749.2011.04043.x. Epub 2011 Jul 14.

DOI:10.1111/j.1469-8749.2011.04043.x

PMID:21752020

Abstract

AIM

To review current studies on the effectiveness of neurofeedback as a method of treatment of the core symptoms of autism spectrum disorders (ASD).

METHOD

Studies were selected based on searches in PubMed, Ovid MEDLINE, EMBASE, ERIC, and CINAHL using combinations of the following keywords: 'Neurofeedback' OR 'EEG Biofeedback' OR 'Neurotherapy' OR 'Mu-Rhythm' OR 'SMR' AND 'Autism' OR 'Autism Spectrum Disorder' OR 'Pervasive Developmental Disorder'.

RESULTS

The existing evidence does not support the use of neurofeedback in the treatment of ASD. Studies with outcomes in favour of neurofeedback might be showing an improvement in comorbid attention-deficit-hyperactivity disorder symptoms rather than a true improvement in core ASD symptoms.

INTERPRETATION

Limitations of this review are those inherent in the studies available, including small sample size, short duration, variable diagnostic criteria, and insufficient control interventions, all causing a lack of generalizability.

摘要

目的

综述神经反馈作为自闭症谱系障碍（ASD）核心症状治疗方法的有效性的现有研究。

方法

通过在 PubMed、Ovid MEDLINE、EMBASE、ERIC 和 CINAHL 中使用以下关键词的组合进行搜索，选择研究：“Neurofeedback”或“EEG 生物反馈”或“Neurotherapy”或“Mu-Rhythm”或“SMR”以及“Autism”或“Autism Spectrum Disorder”或“Pervasive Developmental Disorder”。